Description: 2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
Home Page: www.2curex.com
Fruebjergvej 3
Copenhagen,
2100
Denmark
Phone:
45 22 11 53 99
Officers
| Name | Title |
|---|---|
| Mr. Fernando Andreu | Chief Exec. Officer |
| Mr. Ole Thastrup VD | Co-Founder, Deputy CEO, CSO & Director |
| Ms. Grith Hagel | Co-Founder, COO & Head of Project Management |
| Mr. Kenneth Graabek Johansen | Chief Financial Officer |
| Mr. Mark C. Gray | Director of Communications |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.1232 |
| Price-to-Sales TTM: | 40.6997 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 14 |